LinkedIn Icon
April 3-5, 2019 | Boston, MA

56 Expert Speakers  3 Streams  12+ Hours of Networking

Accelerate the Development of Your NASH Drug Pipeline

Join thought-leaders at the industry’s most comprehensive non-alcoholic steatohepatitis drug development conference.

Focused on drug discovery through to late stage clinical development, the 3rd Annual NASH Summit will empower you with the science and connections to accelerate the development of your NASH candidate.

Across multiple streams of learning you’ll hear from 56 industry experts speakers, including Novartis, Gilead and Allergan, who’ll give detailed presentations on:

  • Exploring the scientific rationale and reviewing the latest advances in strategies for effective combination therapies
  • Confidently enrolling patients onto your clinical trials using multiple biomarkers and non-invasive technologies to diagnose and assess disease regression/progression
  • Robustly translating into clinical development by better recapitulating human NASH in vivo

Engage with 150+ drug developers across 120 organizations next April for your most valuable NASH learning and networking experience of 2019.


“Well planned, and executed. Top notch organization. Gold standard of focused conferences.”
BioTelemetry Research

“Best meeting for industries and valuable information. This meeting makes my understanding for current situation and future perspectives deeper.”
Shionogi Co & Ltd

An excellent opportunity to find out what other pharma are doing and what’s emerging. Very valuable."

highlights for 2018
Media Partner